Ngā hua rapu - Eric Wenzler

  • E whakaatu ana i te 1 - 19 hua o te 19
Whakamahine hua
  1. 1
    An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam

    An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam mā Eric Wenzler, Patrick J. Scoble

    I whakaputaina 2020-10-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Comparison of percent adjusted versus predefined incremental argatroban dosing nomograms in patients with heparin induced thrombocytopenia

    Comparison of percent adjusted versus predefined incremental argatroban dosing nomograms in patients with heparin induced thrombocytopenia mā Mark Jao, Eric Wenzler, Keri S. Kim

    I whakaputaina 2021-08-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy

    Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy mā Lauren Andrews, Scott Benken, Xing Tan, Eric Wenzler

    I whakaputaina 2021-01-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Severe Sepsis Secondary to Persistent Lysinibacillus sphaericus, Lysinibacillus fusiformis and Paenibacillus amylolyticus Bacteremia

    Severe Sepsis Secondary to Persistent Lysinibacillus sphaericus, Lysinibacillus fusiformis and Paenibacillus amylolyticus Bacteremia mā Eric Wenzler, Kamal Kamboj, Joan-Miquel Balada-Llasat

    I whakaputaina 2015-06-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Edoxaban pharmacokinetics during in vitro continuous renal replacement therapy

    Edoxaban pharmacokinetics during in vitro continuous renal replacement therapy mā Eric Wenzler, Kaitlyn Dalton, Lauren Andrews, Scott T. Benken

    I whakaputaina 2024-10-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    The Antimicrobial Stewardship Approach to Combating Clostridium Difficile

    The Antimicrobial Stewardship Approach to Combating Clostridium Difficile mā Eric Wenzler, Surafel G. Mulugeta, Larry H. Danziger

    I whakaputaina 2015-06-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Safety and Efficacy of Apixaban For Therapeutic Anticoagulation in Critically Ill ICU Patients with Severe COVID-19 Respiratory Disease

    Safety and Efficacy of Apixaban For Therapeutic Anticoagulation in Critically Ill ICU Patients with Severe COVID-19 Respiratory Disease mā Eric Wenzler, Monaz H. Engineer, Maidah Yaqoob, Scott T. Benken

    I whakaputaina 2020-10-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia

    A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia mā Mark Biagi, David Butler, Xing Tan, Samah Qasmieh, Eric Wenzler

    I whakaputaina 2019-03-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility

    Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility mā Taylor Abbey, Alesia Vialichka, Michele Jurkovic, Mark Biagi, Eric Wenzler

    I whakaputaina 2022-06-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    BundlED Up: A Narrative Review of Antimicrobial Stewardship Initiatives and Bundles in the Emergency Department

    BundlED Up: A Narrative Review of Antimicrobial Stewardship Initiatives and Bundles in the Emergency Department mā Maressa Santarossa, Emily N. Kilber, Eric Wenzler, Fritzie S. Albarillo, Ethan J. Sterk

    I whakaputaina 2019-11-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Clinical and economic impact of the introduction of a nucleic acid amplification assay for Clostridium difficile

    Clinical and economic impact of the introduction of a nucleic acid amplification assay for Clostridium difficile mā Margaret M. Guinta, Kristen Bunnell, Amanda Harrington, Susan Bleasdale, Larry Danziger, Eric Wenzler

    I whakaputaina 2017-12-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    The importance of pharmacokinetics and pharmacodynamics in antimicrobial drug development and their influence on the success of agents developed to combat resistant gram negative pathogens: A review

    The importance of pharmacokinetics and pharmacodynamics in antimicrobial drug development and their influence on the success of agents developed to combat resistant gram negative p... mā Mary E. Palmer, Lauren J. Andrews, Taylor C. Abbey, Ashley E. Dahlquist, Eric Wenzler

    I whakaputaina 2022-07-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Controversies in Antimicrobial Stewardship: Focus on New Rapid Diagnostic Technologies and Antimicrobials

    Controversies in Antimicrobial Stewardship: Focus on New Rapid Diagnostic Technologies and Antimicrobials mā Eric Wenzler, Jordan R. Wong, Debra A. Goff, Christopher A. Jankowski, Karri A. Bauer

    I whakaputaina 2016-01-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Rapid Diagnostic Test Value and Implementation in Antimicrobial Stewardship Across Low-to-Middle and High-Income Countries: A Mixed-Methods Review

    Rapid Diagnostic Test Value and Implementation in Antimicrobial Stewardship Across Low-to-Middle and High-Income Countries: A Mixed-Methods Review mā Luke S. P. Moore, Maria Virginia Villegas, Eric Wenzler, Timothy M. Rawson, Rita O. Oladele, Yohei Doi, Anucha Apisarnthanarak

    I whakaputaina 2023-06-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Inadequate Cerebrospinal Fluid Concentrations of Available Salvage Agents Further Impedes the Optimal Treatment of Multidrug-Resistant <i>Enterococcus faecium</i> Meningitis and Bacteremia

    Inadequate Cerebrospinal Fluid Concentrations of Available Salvage Agents Further Impedes the Optimal Treatment of Multidrug-Resistant <i>Enterococcus faecium</i> Meningitis and Ba... mā Eric Wenzler, Alina Adeel, Tiffany Wu, Michele Jurkovic, Jeremy Walder, Emily Ramasra, Maureen Campion, Jan Cerny, Nicole M. Theodoropoulos

    I whakaputaina 2021-09-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide

    Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide mā Sarah M Michienzi, Mikayla Johnson, Thomas D Chiampas, Eric Wenzler, Rodrigo M Burgos, Renata O Smith, Melissa E Badowski

    I whakaputaina 2021-07-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Genomic Features Associated with the Degree of Phenotypic Resistance to Carbapenems in Carbapenem-Resistant Klebsiella pneumoniae

    Genomic Features Associated with the Degree of Phenotypic Resistance to Carbapenems in Carbapenem-Resistant Klebsiella pneumoniae mā Zackery P. Bulman, Fiorella Krapp, Nathan B. Pincus, Eric Wenzler, Katherine R. Murphy, Chao Qi, Egon A. Ozer, Alan R. Hauser

    I whakaputaina 2021-10-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Genomic Features Associated with the Degree of Phenotypic Resistance to Carbapenems in Carbapenem-Resistant Klebsiella pneumoniae

    Genomic Features Associated with the Degree of Phenotypic Resistance to Carbapenems in Carbapenem-Resistant Klebsiella pneumoniae mā Zackery P. Bulman, Fiorella Krapp, Nathan B. Pincus, Eric Wenzler, Katherine R. Murphy, Chao Qi, Egon A. Ozer, Alan R. Hauser

    I whakaputaina 2021-10-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States

    Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States mā Kenneth P. Klinker, Levita K. Hidayat, Eric Wenzler, Joan-Miquel Balada-Llasat, Mary Motyl, C. Andrew DeRyke, Karri A. Bauer

    I whakaputaina 2022-05-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: